XML 48 R36.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Policies - Schedule of Recognized Revenue Net of Payments (Detail) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 29, 2019
Jun. 30, 2020
Jun. 29, 2019
Accounting Policies [Abstract]        
Gross revenue from sales to customers $ 3,923 $ 6,215 $ 12,166 $ 11,505
Less: clinical trial payments reducing revenue 532 549 1,245 1,163
Total net revenue [1] $ 3,391 $ 5,666 $ 10,921 $ 10,342
[1] Net revenue by country is categorized based on the location of the end customer.